SCHEMBL8374129

SCHEMBL8374129

Cc1ccc(C(N)=O)c(I)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.51
NNMT P40261 1/20 0.44
IKBKB O14920 1/20 0.40
LIMK1 P53667 1/20 0.40
SIRT3 Q9NTG7 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KDM4E B2RXH2 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRB1 P18505 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27803933 0.82 GABRP (0.46) PARP1TDP1KDM4EKMT2AMEN1
SCHEMBL161323 0.79 NNMT (0.61) PARP1NNMTIKBKBLIMK1SIRT3
SCHEMBL14917429 0.78 PARP1 (0.53) PARP1NNMTIKBKBLIMK1SIRT3
Hydrochloric Acid SCHEMBL2162841 0.78 NNMT (0.59) PARP1NNMTIKBKBLIMK1SIRT3
SCHEMBL5190356 0.76 POLB (0.52) PARP1NNMTIKBKBLIMK1SIRT3
SCHEMBL28141639 0.76 PARP1 (0.51) PARP1NNMTIKBKBLIMK1SIRT3
Hydrochloric Acid SCHEMBL5013614 0.74 PARP1 (0.50) PARP1NNMTIKBKBLIMK1SIRT3
SCHEMBL5013567 0.73 NNMT (0.54) PARP1NNMTIKBKBLIMK1SIRT3
SCHEMBL29903108 0.73 NNMT (0.54) PARP1NNMTIKBKBLIMK1SIRT3
SCHEMBL27605540 0.72 MEN1 (0.43) KDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103420977-B There is the acetylene-derivative of anti-tumor activity 上海医药集团股份有限公司 2016-06-22 CN disclosed
CN-103420977-A Acetylene derivative with anti-tumor activity SHANGHAI PHARMACEUTICAL GROUP CO LTD 2013-12-04 CN disclosed
US-8039450-B2 Boron-containing small molecules as anti-inflammatory agents ANACOR PHARMACEUTICALS, INC. (US) 2011-10-18 US disclosed
US-20090291917-A1 Boron-Containing Small Molecules as Anti-Inflammatory Agents ANACOR PHARMACEUTICALS, INC. (US) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291917-A1 Boron-Containing Small Molecules as Anti-Inflammatory Agents NFKBIA, LITAF, CD68 PARP1 1891/4885NNMT 944/4885IKBKB 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.